Surge In New Home Sales Boost Markets At Midday


A greater than expected surge in new home sales boosted the markets during the midday with the Dow gaining 73 points to 10,116. Nasdaq climbed 25 points to 2236.

On the upside

The Food and Drug Administration will review MELA Sciences' (Nasdaq: MELA) pre-market application for its melanoma detection tool MelaFind.

Central Jersey Bancorp (Nasdaq: CJBK) and Kearny Financial (Nasdaq: KRNY) will merge in a deal valued at approximately $72.3 million.

J.P. Morgan Chase upgraded US Airways Group (NYSE: LCC).

On the downside Investors locked in profits on Sprint (NYSE: S), whose shares surged recently.

Morgan Joseph analyst Shiv Kapoor said that long term growth for Gilead (Nasdaq: GILD) is poor citing a number of drug patents that are set to expire in seven to eight years.

Psagot analyst Limor Gruber upgraded Teva Pharmaceutical (NYSE: TEVA) and raised her price target for the generic drug maker but the stock price fell.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 1 on the NYSE and by nearly 4 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks soared 12 points to 652.

About this Entry

This page contains a single entry by published on May 26, 2010 10:02 AM.

Surging Durable Goods Orders Lift Markets was the previous entry in this blog.

Euro Drops To Weigh Down Markets is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12